AbbVie is a leading research-driven global biopharmaceutical company. The company produces drugs for several different therapeutic areas such as rheumatology, oncology, virology, neurology, etc.

AbbVie’s blockbuster drug, Humira is one of the best-selling drugs globally and accounts for nearly 60% of the company’s revenue. The drug is used to treat psoriasis and rheumatoid arthritis. Other key products include Lupron, Creon, Androgel, and Marinol. The company also has a robust late-stage pipeline across several therapeutic areas.

The company has a large distribution network consisting of AbbVie-owned distribution centers and warehouses from where AbbVie's products reach wholesalers, distributors, and government agencies worldwide. AbbVie operates through only one business segment - Pharmaceuticals.

Key Investment Data

  • Ticker: nyse:ABBV
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Market Cap: 307.34B
  • Market Cap Group: Mega Cap
  • P/E: 47.76
  • Dividend Yield: 3.56%

Competitors

The competitive landscape is important as they compete for the same business. Below is the list of competitors in the same industry. While not displayed, a number of metrics you can also use to evaluate your picks are the Chowder Score, the Relative Strength Index (RSI), the Graham Number, and the Piotroski F-Score.

Ticker Ticker Company Market Cap P/E Yield Aristocrat Graph SectorID IndustryID
LLY NYSE:LLY Lilly 702.64 127.60 0.70 NO 1 8 35
JNJ NYSE:JNJ Johnson & Johnson 377.36 29.66 3.04 YES 1 8 35
MRK NYSE:MRK Merck & Co., Inc. 317.89 918.37 2.46 NO 1 8 35
ABBV NYSE:ABBV AbbVie Inc 307.34 47.76 3.56 YES 1 8 35
AMGN NASDAQ:AMGN Amgen Inc. 155.75 23.32 3.09 NO 1 8 35
PFE NYSE:PFE Pfizer Inc. 155.62 76.69 6.10 NO 1 8 35
BMY NYSE:BMY Bristol Myers Squibb Co. 101.35 12.91 4.82 NO 1 8 35
GILD NASDAQ:GILD Gilead Sciences Inc. 91.79 16.36 4.07 NO 1 8 35
DHT.UN TSE:DHT.UN DIR Healthcare Trust 0.83 0.00 2.74 NO 1 8 35

AbbVie Inc - FAQ

What is the stock ticker for AbbVie Inc?

The stock ticker for AbbVie Inc is NYSE:ABBV.

Is AbbVie Inc a good stock to buy?

You need to consider your investment strategy and how NYSE:ABBV can fit in your portfolio.

The current dividend income score of 5/10 and dividend growth score of 5/10. Those 2 metrics together should help you decide the fit for your portfolio. Be it for income or for growth.

Is AbbVie Inc a Buy, Sell or Hold?

The Dividend Snapshot Opportunity Score of 47 out of 100.

The score reflects the strength of a buy signal but it does not show a sell signal if it's low. The higher the better.

A sell signal is more difficult as it often relies on the reason you bought the stock in the first place.

How can I buy stocks for AbbVie Inc?

You can easily buy the ABBV stock with an online trading platform.

Just make sure the stock fits your risk profile and investment goals.


Use A Winning Investment Strategy

My portfolio is generating over 12% annual returns since 2009. It's not from the beginning of the year or from 2019, it's from 2009 !!! That's a consistent return which means using the rule of 72, I double my portfolio every 6 years.

My approach is simple but you need key data that I have cultivated with the Dividend Snapshot Screeners. No other investment services provide you with easy to understand data but also actionable data. No hidden magic.

In fact, I have tried all of the investment services for dividend investors like a crash test dummy of investment services. Just ask me, and you'll learn why there was nothing I could use out there and that's how the Dividend Snapshot Screeners were borned!